Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Methyltestosterone Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Capsules
  • 1.3.3 Tablet
• 1.4 Market Segment by Application
  • 1.4.1 Global Methyltestosterone Market Share by Application (2019-2025)
  • 1.4.2 Low testosterone levels in men
  • 1.4.3 Delayed puberty in boys
  • 1.4.4 Females
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Methyltestosterone Market Size
  • 2.1.1 Global Methyltestosterone Revenue 2014-2025
  • 2.1.2 Global Methyltestosterone Sales 2014-2025
• 2.2 Methyltestosterone Growth Rate by Regions
  • 2.2.1 Global Methyltestosterone Sales by Regions 2014-2019
  • 2.2.2 Global Methyltestosterone Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Methyltestosterone Sales by Manufacturers
  • 3.1.1 Methyltestosterone Sales by Manufacturers 2014-2019
  • 3.1.2 Methyltestosterone Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Methyltestosterone Revenue by Manufacturers (2014-2019)
  • 3.2.2 Methyltestosterone Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Methyltestosterone Market Concentration Ratio (CR5 and HHI)
• 3.3 Methyltestosterone Price by Manufacturers
• 3.4 Key Manufacturers Methyltestosterone Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Methyltestosterone Market
• 3.6 Key Manufacturers Methyltestosterone Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Capsules Sales and Revenue (2014-2019)
  • 4.1.2 Tablet Sales and Revenue (2014-2019)
• 4.2 Global Methyltestosterone Sales Market Share by Type
• 4.3 Global Methyltestosterone Revenue Market Share by Type
• 4.4 Methyltestosterone Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Methyltestosterone Sales by Application

6 United States

• 6.1 United States Methyltestosterone Breakdown Data by Company
• 6.2 United States Methyltestosterone Breakdown Data by Type
• 6.3 United States Methyltestosterone Breakdown Data by Application

7 European Union

• 7.1 European Union Methyltestosterone Breakdown Data by Company
• 7.2 European Union Methyltestosterone Breakdown Data by Type
• 7.3 European Union Methyltestosterone Breakdown Data by Application

8 China

• 8.1 China Methyltestosterone Breakdown Data by Company
• 8.2 China Methyltestosterone Breakdown Data by Type
• 8.3 China Methyltestosterone Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Methyltestosterone Breakdown Data by Company
• 9.2 Rest of World Methyltestosterone Breakdown Data by Type
• 9.3 Rest of World Methyltestosterone Breakdown Data by Application
• 9.4 Rest of World Methyltestosterone Breakdown Data by Countries
  • 9.4.1 Rest of World Methyltestosterone Sales by Countries
  • 9.4.2 Rest of World Methyltestosterone Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Impax Laboratories
  • 10.1.1 Impax Laboratories Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Methyltestosterone
  • 10.1.4 Methyltestosterone Product Introduction
  • 10.1.5 Impax Laboratories Recent Development
• 10.2 Bausch Health
  • 10.2.1 Bausch Health Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Methyltestosterone
  • 10.2.4 Methyltestosterone Product Introduction
  • 10.2.5 Bausch Health Recent Development
• 10.3 HARBIN PHARMACEUTICAL GROUP
  • 10.3.1 HARBIN PHARMACEUTICAL GROUP Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Methyltestosterone
  • 10.3.4 Methyltestosterone Product Introduction
  • 10.3.5 HARBIN PHARMACEUTICAL GROUP Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Methyltestosterone Sales Channels
  • 11.2.2 Methyltestosterone Distributors
• 11.3 Methyltestosterone Customers

12 Market Forecast

• 12.1 Global Methyltestosterone Sales and Revenue Forecast 2019-2025
• 12.2 Global Methyltestosterone Sales Forecast by Type
• 12.3 Global Methyltestosterone Sales Forecast by Application
• 12.4 Methyltestosterone Forecast by Regions
  • 12.4.1 Global Methyltestosterone Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Methyltestosterone Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Methyltestosterone, sold under the brand names Android, Metandren, and Testred among others, is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, at low doses as a component of menopausal hormone therapy for menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women, and to treat breast cancer in women. It is taken by mouth.
In 2019, the market size of Methyltestosterone is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Methyltestosterone.

This report studies the global market size of Methyltestosterone, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Methyltestosterone sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Impax Laboratories
Bausch Health
HARBIN PHARMACEUTICAL GROUP
...

Market Segment by Product Type
Capsules
Tablet

Market Segment by Application
Low testosterone levels in men
Delayed puberty in boys
Females

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Methyltestosterone status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Methyltestosterone manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Methyltestosterone are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025